Disputes Continue Between Foreign Pharmaceutical Manufacturers and the Korean Authorities
The battle between multinational pharmaceutical manufacturers and the South Korean government continues as the proposed “reference pricing system” moves forward. The reference pricing system, which plans to cut current reimbursement rates for medical treatment in Korea, will have a considerable effect on... Read More